A nurse is caring for a client who has breast cancer and is postoperative following a bilateral mastectomy. Which of the following statements indicates the client has an altered body image?

Choice A reason: Preventing leakage is not the primary purpose of flushing an intermittent infusion device. Flushing maintains patency by clearing blood or medication residue, preventing clots or blockages. Leakage is addressed by proper capping or clamping, not flushing, making this statement incorrect as it misrepresents the procedure’s purpose.
Choice B reason: Flushing an infusion device does not contribute to hydration, as the flush solution (typically saline) is minimal and not intended for fluid replacement. The purpose is to maintain catheter patency by clearing debris or clots. This statement is incorrect, as it inaccurately suggests a hydration benefit unrelated to the procedure.
Choice C reason: Flushing an intermittent infusion device with saline clears blood or medication residue from the catheter, preventing occlusion and maintaining patency. Blood left in the line can clot, increasing infection risk or blocking the device. This statement accurately reflects the procedure’s purpose, ensuring continued functionality for future medication administration.
Choice D reason: Flushing does not ensure sterility, as the device is already in place and exposed to the bloodstream. Sterility is maintained during insertion or access, not flushing. The primary goal is patency, not sterilization, making this statement incorrect as it misaligns with the procedure’s clinical purpose.

Choice A reason: Penicillin, an antibiotic, has no known interactions with saw palmetto, a herbal supplement used for BPH. Saw palmetto affects prostate function, not antibiotic metabolism, so this combination is safe, making it an incorrect choice for an adverse interaction.
Choice B reason: Ipratropium, used for respiratory conditions, does not interact with saw palmetto, which targets prostate health. Their mechanisms are unrelated, and no significant drug-herb interaction exists, making this medication an incorrect choice for an adverse interaction with saw palmetto.
Choice C reason: Zolpidem, a sedative, has no documented interactions with saw palmetto. Saw palmetto’s effects on prostate tissue do not influence zolpidem’s central nervous system actions, so this combination is safe, making it incorrect for an adverse interaction.
Choice D reason: Finasteride, used for BPH, may interact with saw palmetto, as both reduce prostate size via similar mechanisms (inhibiting 5-alpha-reductase). Combined use can amplify effects or cause additive side effects, making this a potential adverse interaction, thus the correct choice.